Rekombinanter B7-H2 (Prezalumab Biosimilar) Antikörper
Kurzübersicht für Rekombinanter B7-H2 (Prezalumab Biosimilar) Antikörper (ABIN7490910)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Verwendungszweck
- Anti-B7-H2 (prezalumab biosimilar) mAb
-
Produktmerkmale
- AMG557, AMG-557, MEDI-5872
-
Aufreinigung
- Purified from cell culture supernatant by affinity chromatography
-
Isotyp
- IgG2
-
-
-
-
Applikationshinweise
- Flow Cyt 1:100
-
Kommentare
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute with deionized water
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Haltbarkeit
- 12 months
-
-
- B7-H2 (Prezalumab Biosimilar)
-
Substanzklasse
- Biosimilar
-
Hintergrund
- Synonyms: ICOSLG, B7-H2, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, LICOS, ICOS ligand
-
UniProt
- O75144
Target
-